Skip to content
Home/Companies/Biotech/Addition Therapeutics
AT

Addition Therapeutics

Biotech·US·Active·1yr hold

Addition Therapeutics is a biotech company, headquartered in US.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Addition Therapeutics?

Addition Therapeutics is currently owned by Abingworth through Abingworth Bioventures IX (2023 vintage), since 2025.

Hand-verified · updated 2026-07-08

Abingworth
Investor
Abingworth
Abingworth Bioventures IX · 2023 · VC

Key facts

HQUS
SectorBiotech
StatusActive

More from Abingworth Bioventures IX

Other portfolio companies in the same fund.

cAMPfield
Active
BiotechUS· 2026
R1 Therapeutics
Active
BiotechUS· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings